Morning News

Trump Says U.S. Will Allow Nvidia H200 Chip Sales to China, Get 25% Cut

By Nadine PEREIRA
Published on Tue, 09.Dec.2025

Topic of the day

President Trump said he would let Nvidia export its H200 chip to China and that the U.S. would receive a 25% cut, his latest bid to make money for the government in an unusual agreement with a private company. “I have informed President Xi of China that the United States will allow Nvidia to ship its H200 products to approved customers in China and other countries under conditions that allow for strong national security,” Trump said on Truth Social. He added: “25% will be paid to the United States of America.” The move is a boon for Nvidia, which has fought for months to maintain access to the world’s second-largest economy. The company had agreed earlier this year to give the U.S. 15% of the China sales from a lower-performing chip, only for the Chinese to scuttle those plans as part of continuing trade talks between the two sides.

Swiss stocks

The Swiss market got off to a slightly weak start on Monday but recovered soon and stayed firm right through the day's session to settle on positive note thanks to strong buying at several counters. The benchmark SMI, which climbed to 13,000.14, settled with a gain of 45.12 points or 0.35% at 12,981.42. Roche Holding gained about 2.2%, and Holcim gained nearly 2%. Sandoz Group climbed 2.1% after the company said that it has completed the acquisition of Just-Evotec Biologics EU SAS from Evotec SE. UBS Group finished with a gain of 1.75%, and Logitech International ended 1.4% up. Galderma Group, ABB, Lonza Group, Kuehne + Nagel and Swiss Re gained 0.8 to 1.1%. Swatch Group ended 2.3% down. Alcon closed lower by 1.77%, Givaudan drifted down 1.37% and Sika settled 1.25% down. SGS, Sonova, Amrize, Richemont, Nestle and Geberit also closed weak. Survey results from the State Secretariat for Economic Affairs, or SECO, showed that confidence among Swiss consumers remained less negative in November. The consumer confidence index rose to -34 in November from -37 in October. That was in line with expectations. In the corresponding month last year, the reading was also -37.0. Among the four components, the economic outlook index negatively contributed, while past financial situation, financial outlook, and moment to make major purchases were higher compared to last year. The index measuring financial outlook strengthened to -28.7 from -33.1.

International markets

Europe
The major European markets closed on a slightly weak note on Monday as investors mostly stayed cautious, looking ahead to the interest rate decision from the Federal Reserve this week. The pan European 600 edged down 0.07%. The U.K.'s FTSE 100 drifted down 0.23% and France's CAC 40 ended down by 0.08%, while Germany's DAX crept up 0.07%. Switzerland's SMI climbed 0.35%. Among other markets in Europe, Czech Republic, Denmark, Netherlands, Russia and Sweden ended weak. Finland, Greece, Iceland, Ireland, Norway, Poland, Spain and Turkiye closed higher, while Belgium and Portugal ended flat. In the UK market, Babcock International, Scottish Mortgage, Polar Capital Technology Trust, Rolls-Royce Holdings, Prudential, Pershing Square Holding, IAG and Standard Chartered gained 1 to 2.7%. Unilever slid 6.6% The consumer goods giant announced that it has completed the demerger of its ice cream business, now known as The Magnum Ice Cream Company (TMICC). Barratt Redrow, JD Sports Fashion, Persimmon and Entain closed lower by 3 to 4%. Marks & Spencer, Berkeley Group Holdings, Land Securities, Burberry Group, Relx and Hikma Pharmaceuticals lost 2 to 2.7%. In the German market, Bayer rallied more than 4.5%. Rheinmetall climbed up nearly 3.5%. Deutsche Bank, MTU Aero Engines, Commerzbank, Porsche Automobil Holding and Deutsche Boerse gained 1 to 1.5%. Shares of Germany metals company Kloeckner and Co shares soared 25%. The company has confirmed it is in discussions regarding a potential voluntary takeover offer from U.S. metals processor Worthington Steel.

United States
Stocks moved to the upside at the start of trading on Monday but moved lower over the course of the trading session. The major averages pulled back off their early highs and into negative territory. The major averages staged a short-lived recovery attempt in mid-day trading but all ended the day in the red. The Dow fell 215.67 points or 0.5 percent to 47,739.32, the Nasdaq edged down 32.22 points or 0.1 percent to 23,545.90 and the S&P 500 decreased 23.89 points or 0.4 percent to 6,846.51. The modest pullback on Wall Street may partly have reflected profit taking following recent strength in the markets, which saw the Nasdaq and S&P 500 reach their best closing levels in a month last Friday. Overall trading activity remain was subdued, however, as traders looked ahead to the Federal Reserve's monetary policy decision on Wednesday. With the Fed widely expected to lower interest rates by another quarter point, traders are likely to pay close attention to the accompanying statement for clues about the likelihood of further rate cuts next year. Significant weakness was also visible among biotechnology stocks, as reflected by the 1.6 loss posted by the NYSE Arca Biotechnology Index. Utilities, natural gas and healthcare stocks also saw notable weakness, while networking, computer hardware and semiconductor stocks saw some strength on the day.

Asia
Asian stock markets are down on Tuesday. The biggest losses are once again in Hong Kong, where the Hang Seng Index is down 1.0 per cent. The Shanghai Composite is down 0.1 per cent and the Kospi in Seoul is down 0.4 per cent. Chip stocks in particular are showing losses in Hong Kong.

Bonds
In the U.S. bond market, treasuries are extending the downward move seen over the two previous sessions. Subsequently, the yield on the benchmark ten-year note, which moves opposite of its price, is up by 4.3 basis points at 4.182 percent.

Analysis
LBBW lowers Swiss Re target to CHF 140 (155) – Hold
UBS lowers Porsche AG target to EUR 44 (46) – Neutral
DZ Bank lowers Brenntag target to EUR 41 (45) – Sell

Produced by MBI Martin Brückner Infosource GmbH & Co. KG on behalf of Swissquote. All news is acquired with journalistic accuracy. No liability is assumed for delays or errors.

Follow us
Be in the know

Sign up to our newsletter and receive a monthly selection right in your inbox


Sponsors
UEFA Europa LeagueGenève ServetteZSC Lions

General Information
Swissquote MEA Ltd. (“SQMEA”) is a company incorporated in the Dubai International Financial Centre (“DIFC”) and regulated by the Dubai Financial Services Authority (“DFSA”). Swissquote Bank SA (“SQB”) is incorporated in Switzerland and regulated by the Swiss Financial Market Supervisory Authority (“FINMA”). The Swissquote Rep Office is licensed by the Central Bank of the United Arab Emirates to carry out representative office activities only.

No Offer or Advice
The content of this website is provided for information purposes only and does not constitute investment advice, solicitation, or an offer to buy or sell any financial instruments. Visitors should not rely solely on the information contained herein to make investment decisions. We recommend seeking independent financial, legal, and tax advice before making any investment.

Product Availability
Certain products, services, or financial instruments described on this website are offered exclusively by Swissquote Bank SA (Switzerland) and are not available through SQMEA or the Swissquote Rep Office. Access to and use of each product or service is subject to the respective terms, conditions, and regulatory requirements of the entity offering it.

Risk Warning
Investing in financial instruments involves risk, including the possible loss of capital. Past performance is not a reliable indicator of future results. For more details, please refer to our Risks Involved in Trading Financial Instruments disclosure.

AI-generated content
Some of the visual content on our website has been generated and/or enhanced using artificial intelligence (AI) applications. However, all content undergoes thorough human review and approval to ensure its accuracy, relevance, and compliance with the needs of our users and clients.